Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-4029 in Acute Ischemic Stroke
NCT07739160Phase 2Not yet recruiting
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Oct 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-4029 in ischemic stroke, sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
HRS-4029
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07739160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739160.